Faculty Information - Yuji Nojima

（Last updated : 2024-09-12 08:45:21）

Yuji Nojima
Department Kawasaki Medical School Kawasaki Medical School, Department of General Thoracic Surgery,

Position Assistant Professor

■ Journal

1.	2023/11/10	A case of an atypical variant of type A thymoma presenting with a gradually enlarging tumor over a 10-year period
2.	2023/11/01	INFORMED CONSENT IN SURGERY FOR PRIMARY LUNG CANCER
3.	2022/03/23	A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis
4.	2021/11	Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
5.	2021/08/06	The biological Characteristics of Solid Components are Different between Part-Solid-Type and Solid-Type in Lung Adenocarcinoma
6.	2021/01/24	Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
7.	2020/09/01	Perioperative Therapy for Non-Small Cell Lung Cancer - Current Status and Future Perspective -
8.	2019/11/26	Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
9.	2019/08	Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer
10.	2019/05	Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
11.	2018/10	Deciduoid type malignant pleural mesothelioma: a case report
12.	2018/08	Impact of COX2 Inhibitor for Regulation of PD-L1 Expressioin in Non-small Cell Lung Cancer
13.	2017/10	Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.
14.	2017/08	Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.
15.	2017/07	PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
16.	2016/12	Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
17.	2016/03	MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small-cell lung cancer
18.	2015/12	Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells.
19.	2015/09	Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
20.	2015/09	Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small cell lung cancer
21.	2015/08	Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
22.	2015/02	Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
23.	2014/11	Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
24.	2014	Clinical significance of vascular endothelial growth factor and Delta-like ligand 4 in small pulmonary adenocarcinoma
25.	2013	CT, MRI, and 18F-FDG PET-CT findings of pulmonary benign metastasizing leiomyoma: A case report
Display 5 items
Display all(25)

■ Presentation

1.	2024/09/09	Serum NY-ESO-1 and XAGE1 antibodies are diagnostic and cancer-specific immunomonitoring markers in NSCLC （Poster notice，General）
2.	2023/10/20	Feasibility of Sublobar Resection for Small-Sized Peripheral Stage IA Squamous Cell Carcinoma （Speech，General）
3.	2023/04/27	Informed Consent in Surgery for Primary Lung Cancer （Speech，Panelist at Symposium/Workshop (Applied)）
4.	2016/12/07	Comparison of Clinicopathological and Immunohistochemical features in Lung Invasive Mucinous Adenocarcinomaaccording to Computed Tomography Findings. （Poster notice，General）

■ Belonging society

1.	2011～	Japan Surgical Society
2.	2013/12～	General Thoracic and Cardiovascular Surgery